Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Drug selection for anti-inflammatory therapy of dry eye disease].

Created on 08 Sep 2026

Authors

Z G Liu, Y Liu

Published in

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology. Volume 62. Issue 9. Pages 765-773. Sep 11, 2026.

Abstract

Dry eye disease is a multifactorial chronic ocular surface disorder, in which inflammatory response plays a pivotal role in its onset and progression. In recent years, with a deepening understanding of the pathogenesis of dry eye and an increasing clinical application of various anti-inflammatory drugs, the appropriate and precise selection of these agents for anti-inflammatory therapy has become of paramount significance in improving clinical outcomes. Starting with the importance of anti-inflammatory therapy for dry eye, this article discusses and summarizes current research evidence and clinical experience regarding the clinical evaluation of inflammation in dry eye, anti-inflammatory therapy, combination anti-inflammatory therapy and its drug selection, perioperative management, and patient education. The aim is to provide a scientific, standardized, and practical diagnostic and therapeutic reference for clinical practice.

PMID:
42706150
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement